Trial Profile
A multicenter, randomized, open label study to compare the safety and efficacy of levofloxacin with that of imipenem/cilastatin in the treatment of nosocomial pneumonia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 May 2009
Price :
$35
*
At a glance
- Drugs Levofloxacin (Primary) ; Imipenem/cilastatin
- Indications Bacterial infections; Nosocomial pneumonia
- Focus Therapeutic Use
- 26 May 2009 Planned number of patients changed from 400 to 438 as reported by ClinicalTrials.gov.
- 20 Nov 2005 New trial record.